Vida Ventures, LLC 4
4 · Oyster Point Pharma, Inc. · Filed Nov 4, 2019
Insider Transaction Report
Form 4
Vida Ventures, LLC
10% Owner
Transactions
- Conversion
Common Stock, par value $0.001 per share
2019-11-04+778,468→ 778,468 total - Purchase
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+185,000$2,960,000→ 963,468 total - Conversion
Series B Convertible Preferred Stock
2019-11-04−778,468→ 0 total→ Common Stock, par value $0.001 per share (778,468 underlying)
Footnotes (1)
- [F1]These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date.